ira pastor

Dr. Gladys Kalema-Zikusoka, is the Founder and CEO of Conservation Through Public Health (CTPH - https://ctph.org/), a 16-year old non-profit organization, based in Uganda, that promotes conservation by improving the quality of life of people and wildlife to enable them to coexist in and around protected areas in Africa, and she has become one of the leading conservationists and scientists working to save the critically endangered mountain gorillas of East Africa. Dr. Kalema-Zikusoka is also on the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) of the World Health Organization (https://www.who.int/groups/scientific-advisory-group-on-the-origins-of-novel-pathogens-(sago)/about) Dr. Kalema-Zikusoka trained as a veterinarian at the University of London’s Royal Veterinary College. Between 1996 and 2000, she set up the first Veterinary Unit at the Uganda Wildlife Authority. From 2000 to 2003, she completed a zoological medicine residency and masters in specialized veterinary medicine at North Carolina State University and North Carolina Zoological Park. Dr. Kalema-Zikusoka became an Ashoka Fellow in 2007 for merging Uganda’s wildlife management and rural public health programs to create common resources for both people and animals. Prior to setting up CTPH, Dr. Kalema-Zikusoka also did a certificate in Non-profit management from Duke University. Most recently in 2016, she completed an MBA in Global Business and Sustainability – Social Entrepreneurship Track. Dr. Kalema-Zikusoka's most recent awards include the 2017 World Wildlife Day Award from the Ministry of Tourism, Wildlife and Antiquities (MTWA) for outstanding contribution to conservation in Uganda and 2017 Golden Jubilee Award from the President of Uganda for distinguished service to the nation as a veterinarian and conservationist on International Women’s Day. Other awards include San Diego Zoo’s 2008 “Conservation in Action Award,” the 2009 Whitley Gold Award for outstanding leadership in grassroots nature conservation; 2011 Wings World Quest Women of Discovery Humanitarian Award, and 2014 CEO Communications Africa’s Most Influential Women in Business and Government Award in Medicine and Veterinary category. Under Dr. Kalema-Zikusoka's leadership, Conservation Through Public Health won the Global Development Network 2012 Japanese Most Innovative Development Project Award for scaling social service delivery. Dr. Kalema-Zikusoka recently became a National Geographic Explorer and winner of the Sierra Club’s 2018 EarthCare Award, 2019 Finalist for the Tusk Award for Conservation in Africa, the 2020 Uganda Veterinary Association World Veterinary Day Award and the 2020 Aldo Leopold award. She is also on the leadership council of Women for the Environment in Africa.

Dr. Satchidananda ("Satchin") Panda, is Professor, Regulatory Biology Laboratory, and Rita and Richard Atkinson Chair, at the Salk Institute for Biological Studies, La Jolla, California (https://www.salk.edu/scientist/satchidananda-panda/), where his research focuses on the circadian regulation of behavior, physiology and metabolism in model organisms and in humans. Dr. Panda is also a founding executive member of the Center for Circadian Biology at the University of California, San Diego (https://ccb.ucsd.edu/). With a PhD from The Scripps Research Institute, La Jolla, California, and his postdoctoral research at the Genomics Institute of the Novartis Research Foundation, San Diego, Dr. Panda’s laboratory is interested in understanding the molecular mechanisms of this biological clock (or circadian oscillator), which in most organisms coordinates behavior and physiology with the natural light-dark cycle. Among Dr. Panda's discoveries include a blue-light sensing cell type in the retina which entrains our master circadian clock, affects mood, and regulates the production of sleep hormone melatonin, as well as his discovery that maintaining a daily feeding-fasting cycle – popularly known as Time-restricted feeding (TRF) – can prevent and reverse metabolic diseases. Based on a feasibility study in humans, his lab is currently carrying out a smartphone based study (www.mycircadianclock.org) to assess the extent of circadian disruption among adults. Dr. Panda's laboratory uses genetic, genomics and biochemical approaches to identify genes under circadian regulation in different organs and to understand the mechanisms of such regulation. Dr. Panda is also a Pew Biomedical Scholar, a recipient of the Julie Martin Mid-Career Award in Aging Research, is extensively published in the scientific literature, and is also the author of the books: The Circadian Code: Lose Weight, Supercharge Your Energy, and Transform Your Health from Morning to Midnight and The Circadian Diabetes Code: Discover the Right Time to Eat, Sleep, and Exercise to Prevent and Reverse Prediabetes and Diabetes.

Iris Van der Veken is Executive Director and Board Member of the Responsible Jewellery Council (https://www.responsiblejewellery.com), the world’s leading standard setting organization for the jewellery industry, promoting standards that underpin people’s trust in the worldwide jewellery. Responsible Jewellery Council was founded in 2005 by 14 member organizations including: ABN AMRO, BHP Billiton Diamonds, Cartier, World Jewellery Confederation, Diamond Trading Company (part of De Beers), Diarough, Jewelers of America, National Association of Goldsmiths (UK), Newmont Mining, Rio Tinto, Rosy Blue, Signet Group, Tiffany & Co., and Zale Corporation. With a University of Antwerp Bachelor of Law, Iris is a coalition-builder with over 20 years global experience of working in technology, diamonds and jewelry, fashion and government. Iris was actively involved in the development of the Responsible Jewellery Council (RJC) Code of Practices, and managed the first global RJC pilot audit in partnership with SGS - the world’s leading inspection, verification, testing and certification company. Iris is also a board member of Diamonds Do Good (https://www.diamondsdogood.com), a global nonprofit organization whose mission is supporting programs that develop and empower people in natural diamond communities and sharing these stories of positive impact. Iris established and chaired the Network of the United Nations Global Compact Belgium in partnership with the Belgian Ministry of Foreign Affairs, Foreign Trade and Development Cooperation, chaired the consultative and advisory body to the Office of the Children’s Rights Commissioner in Flanders, and was honored by the Minister of Foreign Affairs, Foreign Trade and European Affairs of Belgium for initiating the Global Compact and for her work on promoting corporate social responsibility with a focus on human rights including children’s rights and the role of business.

Currently the global beauty industry represents a US$500 billion market, and makeup represents about US$100 billion of that total. Millions of women rely on beauty tutorials for makeup ideas and beauty tips, but find it challenging to recreate professional makeup looks, as they are following makeup application instructions for faces that do not look like their own. As a result, they are not getting their best makeup look, and they are being forced to compare themselves to other women, impacting their confidence. Jennifer Christenson, is the Founder & CEO of FaceTrace Inc. (https://www.facetracebeauty.com/), an innovative company with a novel mobile app that uses proprietary technologies, including augmented reality, to guide women and beauty lovers in properly applying cosmetics without having to visit an in-store beauty counter, hire a professional makeup artist, or attempt to follow online makeup tutorials. Jennifer is also Co-Founder and CEO of JMP Global, which works in the areas of digital media, social networking, and event creation and management. Jennifer has her undergraduate degree from University of Michigan in Psychology / PreMed, has been a producer / host of several Chicago area television shows, was a Miss Illinois USA 2012 First Runner Up & Humanitarian Award Recipient, and is an accomplished author of the book Real by Jennifer Christenson.

Dr. Patrick van der Smagt is Director of ArtificiaI Intelligence Research, Volkswagen AG, and Head of Argmax.AI (https://argmax.ai/), the Volkswagen Group Machine Learning Research Lab, in Munich, focusing on a range of research domains, including probabilistic deep learning for time series modelling, optimal control, reinforcement learning robotics, and quantum machine learning. Dr. van der Smagt is also a research professor in the Computer Science faculty at Eötvös Loránd University in Budapest. Dr. van der Smagt previously directed a lab as professor for machine learning and biomimetic robotics at the Technical University of Munich while leading the machine learning group at the research institute fortiss, and before that, founded and headed the Assistive Robotics and Bionics Lab at DLR, the German Aerospace Center. Besides publishing numerous papers and patents on machine learning, robotics, and motor control, Dr. van der Smagt has won a number of awards, including the 2013 Helmholtz-Association Erwin Schrödinger Award, the 2014 King-Sun Fu Memorial Award, the 2013 Harvard Medical School/MGH Martin Research Prize, the 2018 Webit Best Implementation of AI Award, and best-paper awards at various machine learning and robotics conferences and journals. Dr. van der Smagt also serves as a scientific reviewer for governmental funding organizations and served on various conference and journal boards. Dr. van der Smagt is founding chairman of a non-for-profit organization for Assistive Robotics for tetraplegics, and co-founder of various tech companies. In 2018, he started a for-good initiative called 10-to-GO (https://10togo.eu/), by supporting teams using machine learning for the United Nations Sustainable Development Goals. Also then, he initiated etami (https://www.etami.eu/en.html), an initiative on Ethical and Trustworthy Artificial and Machine Intelligence, creating an organization with almost 20 multinationals and universities. Dr. van der Smagt has his Master of Science (M.Sc.), Computer Science from Vrije Universiteit Amsterdam, and his Doctor of Philosophy (Ph.D.), Computer and Information Sciences, from University of Amsterdam.

 Ms. Bayan Abusalameh is a 2020/2021 Chevening Scholar in Advanced Mechanical Engineering, at Queen Mary University of London (QMUL), who just finished off her Master’s Dissertation entitled “An Innovative Structural Design For a 1U CubeSat” (The Palestine-1) Ms. Abusalameh is also a member of the Institution of Mechanical Engineers Unmanned Aerial System (UAS) team of QMUL. Ms. Abusalameh has her Bachelor's Degree in Mechanical Engineering from Birzeit University and her MSC in Advanced Mechanical Engineering from Queen Mary University of London. 

Mati Gill is the Chief Executive Officer, of AION Labs (https://aionlabs.com/), a company recently launched and backed by a coalition of pharma and tech leaders, including AstraZeneca, Merck, Pfizer, Teva, Amazon Web Services (AWS), and the Israel Biotech Fund (IBF) and Israel Innovation Authority, to improve the whole drug discovery & drug development process with AI and computational biology. Mati has an MBA (Healthcare & Innovation) and BS degree in law from Reichman University / IDC Herzliya, and has over a decade of experience in leadership roles in the biopharma industry, including most recently as Head of Government Affairs, Corporate & International Markets, at Teva Pharmaceuticals. Mati also spent 4 years as Member Of The Board Of Advisors and Directors, at Sanara Ventures, a healthcare investment platform backed by Philips & Teva, providing Pre-seed, Seed and A round financing to young companies. Prior to Teva, Mati was Chief of Staff to Israel's Minister of Public Security.

Dr. Morgan Levine, PhD (https://www.morganlevinelab.com/) is Assistant Professor of Pathology and Epidemiology, at the Yale School of Medicine. Dr. Levine is also a member of both the Yale Combined Program in Computational Biology and Bioinformatics, and the Yale Center for Research on Aging. Her work relies on an interdisciplinary approach, integrating theories and methods from statistical genetics, computational biology, and mathematical demography to develop biomarkers of aging for humans and animal models using high-dimensional -omics data. As PI or co-Investigator on multiple NIH-, Foundation-, and University-funded projects, she has extensive experience using systems-level and machine learning approaches to track epigenetic, transcriptomic, and proteomic changes with aging and incorporate this information to develop measures of risk stratification for major chronic diseases, such as cancer and Alzheimer’s disease. Dr. Levine's work also involves development of systems-level outcome measures of aging, aimed at facilitating evaluation for gero-protective interventions. A number of the existing biological aging measures she has developed are being applied in both basic and observational research.

Dr. Sana Farid, MD (https://www.drsanafarid.com/) is a Surgeon, Entrepreneur, and Futurist, who strives to utilize Emerging Technologies to make the world a better place, and has been key to pushing this vision and the boundaries of innovation through her extensive research and development of impactful programs using immersive technologies like Extended Reality (XR). A driving force in the progression of these Immersive Technologies, Dr. Farid has been hailed as one of the top 100 women in XR globally due to her outstanding achievements in creating industry standards, designing implementation strategies and best practices to help organizations take advantage of what immersive technologies have to offer and develop initiatives to make the use of XR safe. Dr. Farid’s major work involves helping organizations implement XR with a successful and scalable strategy and she is an avid researcher determined to use future tech solutions for societal well-being. A qualified surgeon and a distinguished ambassador of women empowerment programs in the region, she supports government and non-governmental initiatives leading them to envision, strategize and streamline AI/AR/VR based programs in various sectors, including healthcare, aviation, education and public services. Dr. Farid obtained her MBBS in Medicine & Surgery from Dow University of Health Sciences, and did a General Surgery Residency at King Hamad University Hospital in Bahrain.

Dr. Evelyne Bischof, MD  is an expert in internal medicine and oncology, with a focus on preventative and precision medicine, bio-gerontology, and geronto-oncology. Dr. Bischof is deeply passionate about next-generation medical technology, and the applications of artificial intelligence for biomedical research and practice. Dr. Bischof spent a decade practicing medicine and performing translational research in Switzerland, US, and China. Dr. Bischof is a medical doctor with an MD from Max Planck Institute for Molecular Biology and Genetics, and interned at Columbia University, Harvard MGH, and Beth Israel Medical Deaconess. Dr. Bischof is the author of over 40 peer-reviewed papers and is a frequent speaker at scientific and medical conferences. Dr. Bischof serves as Assistant Professor - Shanghai University of Medicine and Health Sciences; Associate Faculty Shanghai Jiao Tong University, and Researcher at University Hospital of Basel. In addition to those roles, Dr. Bischof is Longevity Physician at Human Longevity, Inc., Clinical Advisor, Insilico Medicine, and Scientific Advisor, Holmusk. Dr. Bischof is also Chair of the Visionary Board of The Longevity Science Foundation (https://longevity.foundation/), a new Swiss foundation committed to distributing more than $1 billion over the next ten years to research, institutions and projects advancing healthy human longevity and extending the healthy human lifespan to more than 120 years.

Mr. Larry Curley is Executive Director of The National Indian Council on Aging (https://www.nicoa.org/), a 501(c)(3) nonprofit organization founded in 1976 by members of the National Tribal Chairmen’s Association who called for a national organization focused on the needs of aging American Indian and Alaska Native elders. The mission of NICOA is to advocate for improved comprehensive health, social services and economic well-being for American Indian and Alaska Native elders. Mr. Curley is a member of the Navajo Nation with over 40 years of experience working in the aging and healthcare fields. He has worked with Congress, other branches of the federal government, and national organizations on aging to develop support for programs affecting elder American Indians. After receiving his master’s degree in public administration at the University of Arizona, along with a certificate in gerontology, Mr. Curley worked as a gerontological planner at an Area Agency on Aging in Pima County, Arizona, where he was instrumental in establishing a county public fiduciary program. As a lobbyist in Washington, D.C., he successfully advocated for the passage of Title VI of the Older Americans Act, an amendment which he wrote. Mr. Curley directed the Navajo Nation’s Head Start program, one of the five largest Head Start programs in the country, and has served as a nursing home administrator of a tribal, long-term care facility, a hospital administrator in northern Nevada, and as a college instructor at the University of Nevada-Reno and Eastern Washington University. Mr. Curley was named as the assistant dean of the Four Corners region for the Burrell College of Osteopathic Medicine. He’s also served as the public representative on the American College of Physicians Clinical Guidelines Committee, and as the director of program development for the Rehoboth McKinley Christian Health Care Services in northwest New Mexico.

Eric G. Meyer is the Founder and Director of Generation Atomic (https://generationatomic.org/), a nuclear advocacy non-profit which he founded after hearing about the promise of advanced nuclear reactors, and he decided to devote his life to saving and expanding the use of atomic energy. Eric worked as an organizer on several political, union, and issue campaigns while in graduate school for applied public policy, taking time off to attend the climate talks in Paris and sing opera about atomic energy. Eric began his full time nuclear work in May of 2016 with Environmental Progress by organizing marches, rallies, and trainings in California, New York, and Illinois, before leaving to found Generation Atomic in late 2016. In only a short period of time, Generation Atomic has made significant progress in the world of nuclear advocacy. Over the last year they've held several advocacy trainings at conferences, Marched for Science, talked to over tens of thousands voters, and carried the banner for nuclear energy at the climate talks in Morocco, Germany, and Poland. Eric attended University of Minnesota-Duluth where he obtained a Master's Degree in Advocacy and Political Leadership, with Concentrations in Public Sector and Non-profits, and a Bachelor of Arts in Music Performance.

Mr. Viren Shah is Vice President & Chief Digital Officer, at GE Appliances (GEA - https://www.geappliances.com/), the American home appliance manufacturer, now a majority owned subsidiary of the Chinese multinational home appliances company, Haier (https://www.haierappliances.com/). Mr. Shah has been with GEA since October 2018, in which time he was appointed to lead the business through a digital transformation with a focus on data/intelligence at the center of gravity. Prior to becoming part of the Haier company, Mr. Shah was the CIO at Masco Cabinetry, and CIO Council Leader for their parent company, Masco Corporation, the international conglomerate manufacturer of products for the home improvement and new home construction markets. Mr. Shah has more than 20 years of global experience in creating business value using technology with a strong focus on customers for Fortune 10 organizations, such as his decade at the Walmart organization. He has contributed as a senior leader towards the success of startups, turnarounds and global mergers and acquisitions. Mr. Shah implemented “Think Global and Act Local” methodologies, utilizing operational and cultural experience in areas of IT strategy, omnichannel, business development and governance in more than 20 countries across the Americas, Australia, Europe, Asia and Africa. Mr. Shah holds a bachelor’s degree in computer science from Bombay University, a master of business administration degree in international marketing/short-term finance from the New York Institute of Technology, and an executive education certificate in digital marketing strategies for digital economy from the Wharton School.

Dr. Antonio Giordano, MD, Ph.D., (https://www.drantoniogiordano.com/) is President and Founder of the Sbarro Health Research Organization (https://www.shro.org/), which conducts research to diagnose, treat and cure cancer, but also has diversified into research beyond oncology, into the areas of cardiovascular disease, diabetes and other chronic illnesses. Dr. Giordano is also a Professor of Molecular Biology at Temple University in Philadelphia, a 'Chiara fama' Professor in the Department of Pathology & Oncology at the University of Siena, Italy, and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, and the Center for Biotechnology, at Temple's College of Science & Technology. In his research throughout the years, Dr. Giordano has identified numerous tumor suppressor genes, including Rb2/p130, which has been found to be active in lung, endometrial, brain, breast, liver and ovarian cancers, as well as interesting synergistic effects of gamma radiation in combination with this gene, accelerating the death of tumor cells. Dr. Giordano went on to discover Cyclin A, Cdk9 (which is known to play critical roles in HIV transcriptions, inception of tumors, and cell differentiation), and Cdk10. Dr. Giordano also developed patented technologies for diagnosing cancer. Dr. Giordano has published over 400 papers on gene therapy, cell cycle, genetics of cancer, and epidemiology. In 2011, Dr. Giordano and his team uncovered anti-tumor agents that might be effective in the treatment of mesothelioma, a cancer caused by prolonged asbestos exposure, by inducing cell death without harming healthy cells. Dr. Giordano has been involved with many other fascinating programs, including digital health work to see if watching a computer animated avatar could assist women to lose weight, as well as analyzing the environmental relationship among toxic dumping and cancer growth, birth defects, and CNS disorders, due to the Camorra (the Neapolitan Mafia) illegally disposing of toxic waste.

Joanna Bensz is Founder and CEO of Longevity Center (https://longevity-center.eu/), a boutique preventive health and longevity medical center, that focuses on scientifically and medically advanced technologies and protocols for healthy longevity and sustainable health. Joanna is also Founder and CEO of the International Institute of Longevity (IIOL - https://l-institute.com/), an international organization with offices in Liechtenstein and Poland, co-founded in partnership with H.S.H. Prince Michael of Liechtenstein, focusing on developing a healthy longevity agenda in Europe, identifying, highlighting and promoting solutions, technologies and lifestyle choices that prevent chronic and age related diseases leading to increasing vitality and healthy life spans. Over her career, Joanna has spent time in a range of regional, general and business development director positions, with a number of Fortune 500 companies across Central and Eastern Europe, including at the international project management, architectural and engineering PM Group, Lockheed Martin, and at Geopolitical Intelligence Services, an organization providing independent political intelligence, strategic analysis and future scenarios to companies, governments, organizations and individual leaders, also founded by H.S.H. Prince Michael of Liechtenstein. Joanna has also served as the Vice Chairman and Board Member of the American Chamber of Commerce in Poland, and was responsible for development and leadership of AmCham regional offices in Wroclaw and Kraków. Joanna holds a Master of Arts degree in German Studies from University in Wroclaw, as well as a Diploma in Strategic and International Marketing at the Dublin Business School. She also completed the Advanced Management Program at IESE, University of Navarra in Barcelona.

Mike Graglia is the Managing Director & Co-Founder of the SynGAP Research Fund (SRF - https://www.syngapresearchfund.org/), an organization that he set up in 2018 with his wife Ashley, after their son was diagnosed with a rare neurological disease caused by an insufficiency in SynGAP protein, which causes the life-changing diagnoses of Epilepsy, Autism, sleep disorder and intellectual disability. The mission of SRF is to improve the quality of life of SynGAP1 patients through the research and development of treatments, therapies and support systems. Previously, Mike worked at the Emerson Collective, New America Foundation, the Bill and Melinda Gates Foundation, BCG, the World Bank/IFC and the US Peace Corps/Namibia. During his time in Africa he created a small charity to fund girls' education. Mike graduated from Gonzaga University with a BS in mathematics. He then attended the Johns Hopkins School of Advanced International Studies (SAIS) and Columbia Business School.

Dr. Paul A. Offit, MD, (https://www.paul-offit.com/) is an internationally recognized expert in the fields of virology and immunology, Co-Inventor of a landmark vaccine for the prevention of Rotavirus gastroenteritis, and holds multiple titles including - Director of the Vaccine Education Center at Children's Hospital Of Philadelphia (CHOP), Maurice R. Hilleman Chair of Vaccinology and Professor of Pediatrics, Perelmann School of Medicine, University of Pennsylvania, and Adjunct Associate Professor, The Wistar Institute of Anatomy and Biology. Dr. Offit was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention, a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine, and co-editor of the foremost vaccine text, Vaccines. Dr. Offit is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, a Research Career Development Award from the National Institutes of Health, and the Sabin Vaccine Institute Gold Medal. Dr. Offit has published more than 150 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of a landmark rotavirus vaccine recommended for universal use in infants by the CDC. For this achievement, Dr. Offit received the Luigi Mastroianni and William Osler Awards from the University of Pennsylvania School of Medicine, the Charles Mérieux Award from the National Foundation for Infectious Diseases, and was honored by Bill and Melinda Gates during the launch of their Foundation’s Living Proof Project for global health. In addition, he has received numerous other awards and honors for his groundbreaking work. Dr. Offit is also an author of many books including, but not limited to: Vaccinated: One Man's Quest to Defeat the World's Deadliest Diseases, Overkill: When Modern Medicine Goes Too Far, The Cutter Incident: How America's First Polio Vaccine Led to the Growing Vaccine Crisis, Breaking the Antibiotic Habit, Do You Believe in Magic, and his most recent, You Bet Your Life: From Blood Transfusions to Mass Vaccination, the Long and Risky History of Medical Innovation.

 Dr. Natasha Bajema, is a subject matter expert in nuclear nonproliferation, cooperative threat reduction and WMD terrorism, and currently serves as Director of the Converging Risks Lab, at The Council on Strategic Risks, a nonprofit, non-partisan security policy institute devoted to anticipating, analyzing and addressing core systemic risks to security in the 21st century, with special examination of the ways in which these risks intersect and exacerbate one another. The Converging Risks Lab (CRL) is a research and policy development-oriented program designed to study converging, cross-sectoral risks in a rapidly-changing world, which brings together experts from multiple sectors of the security community, to ask forward-thinking questions about these converging risks, and to develop anticipatory solutions. Dr. Bajema is also Founder and CEO of Nuclear Spin Cycle, a publishing and production company specializing in national security, entertainment, and publishing. Prior to this, Dr. Bajema was at the Center for the Study of Weapons of Mass Destruction at the National Defense University, serving as Director of the Program for Emerging Leaders (PEL), as well as serving long-term detail assignments serving in various capacities in the Office of the Secretary of Defense, Acquisitions, Technology and Logistics, Nuclear, Chemical and Biological Defense Programs and in Defense Nuclear Nonproliferation at Department of Energy’s National Nuclear Security Administration. Prior to joining the Center, Dr. Bajema was a Research Associate at the Center on International Cooperation at New York University, where she supported research staff of the High-Level Panel on Threats, Challenges and Change established by the UN Secretary-General. She has also served as a Junior Political Officer in the Weapons of Mass Destruction Branch of the Department for Disarmament Affairs at the United Nations. Dr. Bajema's publications include two co-edited volumes entitled Terrorism and Counterterrorism, and Weapons of Mass Destruction and Terrorism, both of which were published by McGraw Hill. She has also published the novels Bionic Bug, Rescind Order, Genomic Data, and Project Gecko. Dr. Bajema holds an M.A. in international policy from the Monterey Institute of International Studies and a PhD in international relations from the Fletcher School of Law and Diplomacy. 

 Colonel (Ret) Rosendo “Ross” Guieb, is the Executive Director of the new $200-million George H.W. Bush Combat Development Complex (BCDC) on the Rellis Campus at Texas A&M University. The BCDC was developed to support the Army’s desire for a faster procurement process, hoping to take advantage of technology advances at the rates enjoyed by the commercial and private sectors. The BCDC will include the largest enclosed-tube test facility in the U.S. for hypersonic and laser technologies and expansive laboratories and outdoor test grounds for evaluating experimental ground and air vehicles. Colonel Guieb recently retired from the U.S. Army after serving 29 years and most recently had served as a senior member and executive officer to General John M. Murray, the first commanding general of the Army Futures Command (AFC) which leads transformation of Army modernization in order to provide future war fighters with the concepts, capabilities and organizational structures they need to dominate a future battlefield. Colonel Guieb served two tours of duty in Iraq and one in Afghanistan in addition to a brigade command at Fort Hood, TX and multiple deployments in Honduras and Panama. He also worked at the Pentagon, where he was executive officer to then-under-secretary of the Army Ryan McCarthy, who also served as the 24th secretary of the Army. Colonel Guieb has a bachelors in international relations and affairs, and multiple master degrees including in education, national security policy, and business administration. 

 Dr. Nicole Prause, PhD is an American neuroscientist researching human sexual behavior, addiction, and the physiology of sexual response. She is also the founder of Liberos LLC, an independent research institute and biotechnology company. Dr. Prause obtained her doctorate in 2007 at Indiana University Bloomington, with joint supervision by the Kinsey Institute for Research in Sex, Gender, and Reproduction, with her areas of concentration being neuroscience and statistics. Her clinical internship, in neuro-psychological assessment and behavioral medicine, was with the VA Boston Healthcare System's Psychology Internship Training Program. Her research fellowship was in couples' treatment of alcoholism was at Harvard University. Dr. Prause became a tenure track faculty member at Idaho State University at the age of 29. After three years there, she accepted a position as a Research Scientist at the Mind Research Network, a neuro-imaging facility in Albuquerque, New Mexico. In 2012, Dr. Prause was elected a full member of the International Academy of Sex Research and accepted a position as a Research Scientist on faculty at the University of California, Los Angeles in the David Geffen School of Medicine. While there, she was promoted to Associate Research Scientist in 2014. Dr. Prause founded Liberos LLC in 2015 and she continues to practice as licensed psychologist in California.